IL165690A0 - Novel crystalline forms of gatifloxacin - Google Patents
Novel crystalline forms of gatifloxacinInfo
- Publication number
- IL165690A0 IL165690A0 IL16569004A IL16569004A IL165690A0 IL 165690 A0 IL165690 A0 IL 165690A0 IL 16569004 A IL16569004 A IL 16569004A IL 16569004 A IL16569004 A IL 16569004A IL 165690 A0 IL165690 A0 IL 165690A0
- Authority
- IL
- Israel
- Prior art keywords
- gatifloxacin
- crystalline forms
- novel crystalline
- novel
- forms
- Prior art date
Links
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 title 1
- 229960003923 gatifloxacin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38909302P | 2002-06-14 | 2002-06-14 | |
| US42333802P | 2002-11-01 | 2002-11-01 | |
| PCT/US2003/019046 WO2003105851A1 (en) | 2002-06-01 | 2003-06-16 | Novel crystalline forms of gatifloxacin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165690A0 true IL165690A0 (en) | 2006-01-15 |
Family
ID=29740100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16569004A IL165690A0 (en) | 2002-06-14 | 2004-12-09 | Novel crystalline forms of gatifloxacin |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7411067B2 (https=) |
| EP (1) | EP1471911A1 (https=) |
| JP (1) | JP2005532364A (https=) |
| CN (1) | CN1674902A (https=) |
| AU (1) | AU2003243615A1 (https=) |
| CA (1) | CA2489377A1 (https=) |
| IL (1) | IL165690A0 (https=) |
| WO (1) | WO2003105851A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118546A1 (en) * | 2004-06-04 | 2005-12-15 | Matrix Laboratories Ltd | Novel crystalline forms of gatifloxacin |
| CA2621616A1 (en) * | 2007-02-19 | 2008-08-19 | Alcon Research, Ltd. | Topical gatifloxacin formulations |
| JP2010522756A (ja) | 2007-03-29 | 2010-07-08 | プロジェニックス ファーマシューティカルズ，インコーポレーテッド | 結晶形およびその使用 |
| MY180626A (en) | 2013-11-15 | 2020-12-03 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128601C (en) | 1992-01-31 | 2003-07-15 | Hiroyuki Nagano | Quinolone carboxylic acid derivatives in crystalline hydrate form |
| JP3449658B2 (ja) | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| US6413969B1 (en) | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
| US20060142300A1 (en) | 2002-04-08 | 2006-06-29 | Reddy Manne S | Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
-
2003
- 2003-06-16 JP JP2004512754A patent/JP2005532364A/ja active Pending
- 2003-06-16 US US10/462,945 patent/US7411067B2/en not_active Expired - Fee Related
- 2003-06-16 AU AU2003243615A patent/AU2003243615A1/en not_active Abandoned
- 2003-06-16 CA CA002489377A patent/CA2489377A1/en not_active Abandoned
- 2003-06-16 EP EP03760424A patent/EP1471911A1/en not_active Withdrawn
- 2003-06-16 CN CNA038193094A patent/CN1674902A/zh active Pending
- 2003-06-16 WO PCT/US2003/019046 patent/WO2003105851A1/en not_active Ceased
-
2004
- 2004-12-09 IL IL16569004A patent/IL165690A0/xx unknown
-
2008
- 2008-07-01 US US12/217,251 patent/US20080269488A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040038988A1 (en) | 2004-02-26 |
| EP1471911A1 (en) | 2004-11-03 |
| US20080269488A1 (en) | 2008-10-30 |
| AU2003243615A1 (en) | 2003-12-31 |
| WO2003105851A1 (en) | 2003-12-24 |
| CN1674902A (zh) | 2005-09-28 |
| JP2005532364A (ja) | 2005-10-27 |
| US7411067B2 (en) | 2008-08-12 |
| CA2489377A1 (en) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003230192A1 (en) | Novel crystalline forms of aripiprazole | |
| ZA200409981B (en) | Novel formate salt of O-desmethyl-venlafaxine | |
| AP1955A (en) | Novel crystalline modification of the anhydrate ofboscalid | |
| IL165115A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003297594A8 (en) | Crystalline form | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
| IL172006A0 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| AU2003295638A8 (en) | Novel inhibitors of beta-lactamase | |
| IL166592A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| IL165690A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003217437A1 (en) | Novel crystalline forms of lamotrigine | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| PL375437A1 (en) | Synthesis of gatifloxacin | |
| AU2003300874A1 (en) | Crystalline forms of gatifloxacin and processes for preparation | |
| EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
| AU2003230194A1 (en) | Novel crystalline forms of gatifloxacin | |
| GB0329236D0 (en) | Crystalline forms of (+)- and (-)- erthro-mefloquine hydrochloride | |
| IL174063A0 (en) | Crystalline form of gatifloxacin | |
| AU2003238668A1 (en) | Novel crystalline forms of valdecoxib | |
| GB0227730D0 (en) | Novel production of biocompounds | |
| AU2003209670A1 (en) | Novel crystalline forms of trandolapril |